Prof. Shusen Zheng's Group Innovated the Principle for Anticancer Drug Design Published in Advanced

2015-12-24   |  

Self-assembling of individual molecular building blocks—small-molecule prodrugs—promises to facilitate the construction of nanodrugs without the requirement of adjuvant materials. Unfortunately, rationally designing systemically injectable nanoassemblies for those highly hydrophobic chemotherapeutics still represents a great challenge in cancer drug development.